Neuroblastoma Research

Browse by Tags

• HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells.

  Related Articles HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells. Anticancer Drugs. 2008 Oct;19(9):849-857 Authors: Wegener D, Deubzer HE, Oehme I, Milde T, Hildmann C, Schwienhorst... Posted Sep 04 2008, 08:50 AM by PubMed: neuroblastoma Filed under: Anticancer Drugs